Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts

Journal of the National Cancer Institute

Volumn 94, Issue 19, 2002, Pages 1494-1503

  Wang, Fei ^a   Hansen, Rhonda K ^a   Radisky, Derek ^a   Yoneda, Toshiyuki ^b   Barcellos Hoff, Mary Helen ^a   Petersen, Ole W ^c   Turley, Eva A ^d   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; BETA1 INTEGRIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN INHIBITOR; UVOMORULIN;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; BREAST CELL; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CARCINOGENICITY; CELL DEATH; CELL GROWTH; CELL INVASION; CELL POLARITY; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; DRUG DESIGN; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; REVERTANT; SIGNAL TRANSDUCTION;

EID: 0037009820     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.19.1494     Document Type: Article

References (50)

1. Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res 1999;59(7 Suppl): 1757s-63s; discussion 1763s-4s.
2. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-57.
3. Werb Z, Vu TH, Rinkenberger JL, Coussens LM. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS 1999; 107:11-8.
4. Bissell MJ, Radisky D. Putting tumours in context. Nature Rev Cancer 2001;1:46-54.
5. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells [published erratum appears in Proc Natl Acad Sci U S A 1993;90:2556]. Proc Natl Acad Sci U S A 1992;89:9064-8.
6. Briand P, Petersen OW, Van Deurs B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev Biol 1987;23:181-8.
7. Briand P, Nielsen KV, Madsen MW, Petersen OW. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Res 1996;56:2039-44.
8. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-45.
9. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci U S A 1998;95:14821-6.
10. Schiemann S, Schwirzke M, Brunner N, Weidle UH. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin Exp Metastasis 1998;16: 129-39.
11. Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 1999;55:127-36.
12. Paciotti GF, Tamarkin L. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol Endocrinol 1988;2:459-64.
13. Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1987;1: 216-23.
14. Ennis BW, Lippman ME, Dickson RB. The EGF receptor system as a target for antitumor therapy. Cancer Invest 1991;9:553-62.
15. Kato K, Ueoka Y, Tamura T, Nishida J, Wake N. Oncogenic Ras modulates epidermal growth factor responsiveness in endometrial carcinomas. Eur J Cancer 1998;34:737-44.
16. Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 2001;20:4995-5004.
17. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, et al. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999;146: 149-64.
18. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, et al. P13-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated McF-7 cells. EMBO J 2001;20:6050-9.
19. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996;56:4063-70.
20. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989;109:877-89.
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
22. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-52.
23. Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin- 1 -dependent invasive properties. J Biol Chem 1997;272:5007-15.
24. Wang F, Yoneda T, Barcellos-Hoff MH, Bissell MJ. Combinatorial modifications of multiple pathways reverts the malignant phenotype of mammary carcinoma cells MDA-MB231. Mol Biol Cell 1999;10(Suppl): 2024.
25. Sebolt-Leopold JS, Dudley DT, Herrera R, Becelaere KV, Wiland A, Gowan RC, et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999;5:810-6.
26. Nawrocki Raby B, Polette M, Gilles C, Clavel C, Strumane K, Matos M, et al. Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int J Cancer 2001;93:644-52.
27. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-44.
28. Zantek ND, Azimi M, Fedor-Chaiken M, Wang B, Brackenbury R, Kinch MS. E-cadherin regulates the function of the EphA2 receptor tyrosine kinase. Cell Growth Differ 1999;10:629-38.
29. Trusolino L, Cavassa S, Angelini P, Ando M, Bertotti A, Comoglio PM, et al. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 2000;14:1629-40.
30. Morini M, Mottolese M, Ferrari N, Ghiorzo F, Buglioni S, Mortarini R, et al. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000;87:336-42.
31. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000;2:249-56.
32. Tsynes BB, Haugland HK, Bjerkvig R. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. Invasion Metastasis 1997;17:270-80.
33. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, Giancotti FG. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 2001;155:447-58.
34. Pouliot N, Nice EC, Burgess AW. Laminin-10 mediates basal and EGF-stimulated motility of human colon carcinoma cells via alpha(3)beta(1) and alpha(6)beta(4) integrins. Exp Cell Res 2001;266:1-10.
35. Price JT, Tiganis T, Agarwal A, Djakiew D, Thompson EW. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res 1999;59:5475-8.
36. Losasso C, Di Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, et al. Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 2000; 484:194-8.
37. Colognat H, Winkelmann DA, Yurchenco PD. Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 1999;145: 619-31.
38. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-93.
39. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
40. Zhu AJ, Watt FM. Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes. J Cell Sci 1996;109:3013-23.
41. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, et al. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 1998;143:1385-98.
42. Kamei T, Matozaki T, Sakisaka T, Kodama A, Yokoyama S, Peng YF, et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells-regulation by Rho, Rac, and Rab small G proteins. Oncogene 1999;18:6776-84.
43. Expada J, Perex-Moreno M, Braga VM, Rodriguez-Viciana P, Cano A. H-ras activation promotes cytoplasmic accumulation and phosphoinositide 3-OH kinase association of beta-catenin in epidermal keratinocytes. J Cell Biol 1999;146:967-80.
44. Lu Q, Paredes M, Zhang J, Kosik KS. Basal extracellular signal-regulated kinase activity modulates cell-cell and cell-matrix interactions. Mol Cell Biol 1998;18:3257-65.
45. Potempa S, Ridley AJ. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 1998;9: 2185-200.
46. Chen YH, Lu Q, Schneeberger EE, Goodenough DA. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 849-62.
47. Moorehead RA, Fata JE, Johnson MB, Khokha R. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice. Cell Death Differ 2001;8: 16-29.
48. Gimond C, van Der Flier A, van Delft S, Brakebusch C, Kuikman L, Collard JG, et al. Induction of cell scattering by expression of betal integrins in betal-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function. J Cell Biol 1999;147:1325-40.
49. Wilding J, Vousden KH, Soutter WP, McCrea PD, Del Buono R, Pignatelli M. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. Cancer Res 1996;56:5285-92.
50. Hazan RB, Norton L. The epidermal growth factor receptor modulates the Interaction of E-cadherin with the actin cytoskeleton. J Biol Chem 1998; 273:9078-84.